Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M.
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62
Doi: 10.1111/j.1464-410X.2012.11134.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Pichler Martin
- Rainer Peter
- Co-Autor*innen der Med Uni Graz
- Bauernhofer Thomas
- Doleschal Bernhard
- Groschner Klaus
- Höfler Gerald
- Hutterer Georg
- Mächler Heinrich
- Pieske Burkert Mathias
- Samonigg Hellmut
- von Lewinski Dirk
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVES: To examine the acute effects of sunitinib on inotropic function, intracellular Ca(2+) transients, myofilament Ca(2+) sensitivity and generation of reactive oxygen species (ROS) in human multicellular myocardium and isolated mouse cardiomyocytes. To search for microRNAs as suitable biomarkers for indicating toxic cardiac effects. PATIENTS AND METHODS: After exposure to sunitinib (0.1-10 µg/mL) developed force, diastolic tension and kinetic variables were assessed in isolated human myocardium. Changes in myocyte sarcomere length, whole-cell calcium transients, myofilament force-Ca(2+) relationship, and ROS generation were examined in isolated ventricular mouse cardiomyocytes. Microarray and realtime-PCR were used to screen for differentially expressed microRNAs in cultured cardiomyocytes that were exposed for 24 h to sunitinib. RESULTS: We found that higher concentrations of sunitinib (1 and 10 µg/mL) decreased developed force at 30 minutes 76.9 + 2.8 and 54.5 + 6.3%, compared to 96.1 + 2.6% in controls (P < 0.01). Sunitinib exposure significantly decreased sarcomere shortening and Ca2+ transients. Myofilament Ca(2+) sensitivity was not altered, while ROS levels were significantly increased after exposure to the drug. MicroRNA expression patterns were not altered by sunitinib. CONCLUSIONS: Sunitinib elicits a dose-dependent negative inotropic effect in myocardium, accompanied by a decline in intracellular Ca(2+) and increased ROS generation. In clinical practice, these cardiotoxic effects should be considered in cases where cardiac concentrations of sunitinib could be increased.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged - administration & dosage
- Animals - administration & dosage
- Antineoplastic Agents - adverse effects
- Calcium - metabolism
- Dose-Response Relationship, Drug - administration & dosage
- Electron Spin Resonance Spectroscopy - administration & dosage
- Female - administration & dosage
- Heart - drug effects
- Humans - administration & dosage
- In Vitro Techniques - administration & dosage
- Indoles - adverse effects
- Male - administration & dosage
- Mice - administration & dosage
- Mice, Inbred C57BL - administration & dosage
- Myocardial Contraction - drug effects
- Myocytes, Cardiac - drug effects, metabolism
- Protein Kinase Inhibitors - adverse effects
- Pyrroles - adverse effects
- Reactive Oxygen Species - metabolism
- Sarcomeres - drug effects
- Sunitinib - administration & dosage
- Find related publications in this database (Keywords)
- sunitinib
- side effects
- kidney cancer
- cardiotoxicity
- microRNAs